PLA2G16 was first recognized as a type II tumor suppressor gene (Sers et al., 1997) and was identified as a PPARγ target gene, expressed specifically in adipose tissue (Hummasti et al., 2008; Uyama et al., 2009). The gene discussed is SGCG; the disease is neoplasm.